How Do Nephrologists Accept Pharmacists’ Recommendations on Geriatric Patients’ Drug Therapy? A Brief Review

  • Niusha Didehvar Pharm D Candidate, Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  • Leila Sabetnia Department of Nephrology, School of Medicine, Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran
  • Heshmatolah Shahbazian Department of Nephrology, School of Medicine, Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran
  • Kaveh Eslami Department of Clinical Pharmacy, School of Pharmacy, Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran
  • Leila Kouti Department of Clinical Pharmacy, School of Pharmacy, Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran
Keywords: Geriatrics, Nephrology, Pharmacists

Abstract

Geriatric patients are at greater risk of drug related problems due to increased prevalence of chronic diseases and drug consumption. But at the same time, an important issue in the collaboration of pharmacists and physicians, is the acceptance of the pharmacist’s recommendations by other specialties. The present review summarizes the acceptance rate of nephrologists towards pharmacist recommendations.

PubMed and google scholar were searched from 1979 to 2016. The key terms were: physician-pharmacist, physician acceptance, pharmacist intervention, elderly patients, nephrology, renal disorder, pharmacist assessment, geriatrics, physician pharmacist collaboration.

The search for key terms in English and Persian resulted in 13 relevant literatures from 2011-2018. All of the studies demonstrated the positive effect of pharmacist interventions. The acceptance rate of nephrologists is over 60% (and sometimes as high as 84%) in different regions. This topic is relatively young and the specific collaboration of nephrologists and pharmacists has not been studied prior to 2011.

References

1. Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M. Reviewing the definition of “elderly”. Geriatrics & Gerontology International 2006;6(3):149-58.
2. Parsa P, Rezapur-Shahkolai F, Araghchian M, Afshari M, Moradi A. Medical Procedure Problems from the Viewpoint of Elderly Referrals to Healthcare Centers of Hamadan: A Qualitative Study. Iranian Journal of Ageing 2017;12(2):146-55.
3. Locatelli F, Pozzoni P. Chronic kidney disease in the elderly: is it really a premise for overwhelming renal failure? Kidney Int 2006;69(12):2118-20.
4. Björkman IK, Fastbom J, Schmidt IK, Bernsten CB, Group PCotEiER. Drug—Drug Interactions in the Elderly. Ann Pharmacother 2002;36(11):1675-81.
5. Spinewine A, Swine C, Dhillon S, et al. Appropriateness of use of medicines in elderly inpatients: qualitative study. BMJ 2005;331(7522):935.
6. Pasina L, Djade C, Tettamanti M, et al. Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study. J Clin Pharm Ther 2014;39(5):511-5.
7. Greene M, Steinman MA, McNicholl IR, Valcour V. Polypharmacy, drug–drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. J Am Geriatr Soc 2014;62(3):447-53.
8. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007;5(4):345-51.
9. Lee JK, Slack MK, Martin J, Ehrman C, Chisholm‐Burns M. Geriatric patient care by US pharmacists in healthcare teams: systematic review and meta‐analyses. J Am Geriatr Soc 2013;61(7):1119-27.
10. Gillespie U, Alassaad A, Henrohn D, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med 2009;169(9):894-900.
11. Somers A, Robays H, De Paepe P, Van Maele G, Perehudoff K, Petrovic M. Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital. Clin Interv Aging 2013;8:703-9.
12. Mestres C, Agustí A, Hernandez M, Puerta L, Llagostera B. Pharmacist intervention program at different rent levels of geriatric healthcare. Pharmacy (Basel) 2017;5(2). pii: E27.
13. Khalil H. A review of pharmacist recommendations in an aged care facility. Aust J Prim Health 2011;17(1):35-9.
14. Ahmed AK, Brown SH, Abdelhafiz AH. Chronic kidney disease in older people; Disease or dilemma? Saudi J Kidney Dis Transpl 2010;21(5):835- 41.
15. Cabello-Muriel A, Gascón–Cánovas JJ, Urbieta-Sanz E, Iniesta-Navalón C. Effectiveness of pharmacist intervention in patients with chronic kidney disease. Int J Clin Pharm 2014;36(5):896-903.
16. Olsen CG, Tindall WN, Clasen ME, Association AP. Geriatric pharmacotherapy: a guide for the helping professional: American Pharmaceutical Association; 2007.
17. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001;323(7325):1340-3.
18. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu Cy. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med 2004;351(13):1296-305.
19. Modig S, Lannering C, Östgren CJ, Mölstad S, Midlöv P. The assessment of renal function in relation to the use of drugs in elderly in nursing homes; a cohort study. BMC Geriatr 2011;11(1):1.
20. Peterson JF, Kripalani S, Danciu I, et al. Electronic surveillance and pharmacist intervention for vulnerable older inpatients on high-risk medication regimens. J Am Geriatr Soc 2014;62(11):2148-52.
21. Chen CC, Hsiao FY, Shen LJ, Wu CC. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit. Medicine 2017;96(34).
22. Jean-Bart E, Faure R, Omrani S, et al., editors. Role of clinical pharmacist in the therapeutical optimization in geriatric outpatient hospital. Ann Pharm Fr. 2014;72(3):184-93.
23. Rhalimi F, Rhalimi M, Rauss A. Pharmacist’s Comprehensive Geriatric Assessment: Introduction and Evaluation at Elderly Patient Admission. Drugs Real World Outcomes 2017;4(1):43-51.
24. Cornu P, Steurbaut S, Šoštarić S, Mrhar A, Dupont AG. Performance of a clinical decision support system and of clinical pharmacists in preventing drug–drug interactions on a geriatric ward. Int J Clin Pharm 2014;36(3):519-25.
25. Smith SM, Hasan M, Huebschmann AG, et al. Physician acceptance of a physician‐pharmacist collaborative treatment model for hypertension management in primary care. J Clin Hypertens (Greenwich) 2015;17(9):686-91.
26. Guthrie KD, Stoner SC, Hartwig DM, et al. Physicians’ preferences for communication of pharmacist-provided medication therapy management in community pharmacy. J Pharm Pract 2017;30(1):17-24.
27. Qudah B, Albsoul-Younes A, Alawa E, Mehyar N. Role of clinical pharmacist in the management of blood pressure in dialysis patients. Int J Clin Pharm 2016;38(4):931-40.
28. Cortejoso L, Dietz R, Hofmann G, Gosch M, Sattler A. Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany. Clin Interv Aging 2016;11:1343.
29. Weddle SC, Rowe AS, Jeter JW, Renwick RC, Chamberlin SM, Franks AS. Assessment of clinical pharmacy interventions to reduce outpatient use of high-risk medications in the elderly. J Manag Care Spec Pharm 2017;23(5):520-4.
30. Gustafsson M, Sjölander M, Pfister B, Schneede J, Lövheim H. Effects of Pharmacists’ Interventions on Inappropriate Drug Use and Drug-Related Readmissions in People with Dementia-A Secondary Analysis of a Randomized Controlled Trial. Pharmacy (Basel) 2018;6(1). pii: E7
Published
2019-07-16
How to Cite
1.
Didehvar N, Sabetnia L, Shahbazian H, Eslami K, Kouti L. How Do Nephrologists Accept Pharmacists’ Recommendations on Geriatric Patients’ Drug Therapy? A Brief Review. J Pharm Care. 6(3-4):68-71.
Section
Review Article(s)